|
Volumn 20, Issue 1, 2007, Pages 59-61
|
Should we continue screening rhesus D positive women for the development of atypical antibodies in late pregnancy?
|
Author keywords
Antibody; Pregnancy; Rhesus positive; Screening; Third trimester
|
Indexed keywords
RHESUS D ANTIBODY;
ANTIBODY;
ANTIBODY DETECTION;
ARTICLE;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
FEMALE;
FETUS OUTCOME;
HUMAN;
MAJOR CLINICAL STUDY;
PRENATAL CARE;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
RHESUS INCOMPATIBILITY;
THIRD TRIMESTER PREGNANCY;
BLOOD;
BLOOD GROUP RHESUS SYSTEM;
COST BENEFIT ANALYSIS;
DIAGNOSTIC TEST;
ECONOMICS;
IMMUNOLOGY;
NEWBORN HEMOLYTIC DISEASE;
PREGNANCY;
PREGNANCY OUTCOME;
PRENATAL DIAGNOSIS;
UNNECESSARY PROCEDURE;
UTILIZATION REVIEW;
ANTIBODIES;
COST-BENEFIT ANALYSIS;
DIAGNOSTIC TESTS, ROUTINE;
ERYTHROBLASTOSIS, FETAL;
FEMALE;
HUMANS;
PREGNANCY;
PREGNANCY OUTCOME;
PREGNANCY TRIMESTER, THIRD;
PRENATAL DIAGNOSIS;
RETROSPECTIVE STUDIES;
RH-HR BLOOD-GROUP SYSTEM;
UNNECESSARY PROCEDURES;
|
EID: 34248590614
PISSN: 14767058
EISSN: 14764954
Source Type: Journal
DOI: 10.1080/14767050601123317 Document Type: Article |
Times cited : (16)
|
References (8)
|